Sentage (SNTG) Competitors $1.66 +0.03 (+2.09%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock SNTG vs. NRBO, GLBZ, JFU, ANY, BTCT, GRYP, AIHS, MCVT, GREE, and SLNHShould you be buying Sentage stock or one of its competitors? The main competitors of Sentage include NeuroBo Pharmaceuticals (NRBO), Glen Burnie Bancorp (GLBZ), 9F (JFU), Sphere 3D (ANY), BTC Digital (BTCT), Gryphon Digital Mining (GRYP), Senmiao Technology (AIHS), Mill City Ventures III (MCVT), Greenidge Generation (GREE), and Soluna (SLNH). These companies are all part of the "banking" industry. Sentage vs. NeuroBo Pharmaceuticals Glen Burnie Bancorp 9F Sphere 3D BTC Digital Gryphon Digital Mining Senmiao Technology Mill City Ventures III Greenidge Generation Soluna NeuroBo Pharmaceuticals (NASDAQ:NRBO) and Sentage (NASDAQ:SNTG) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, community ranking, risk, media sentiment and valuation. Is NRBO or SNTG more profitable? Sentage's return on equity of 0.00% beat NeuroBo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets NeuroBo PharmaceuticalsN/A -189.12% -122.31% Sentage N/A N/A N/A Does the media favor NRBO or SNTG? In the previous week, Sentage had 1 more articles in the media than NeuroBo Pharmaceuticals. MarketBeat recorded 1 mentions for Sentage and 0 mentions for NeuroBo Pharmaceuticals. Sentage's average media sentiment score of 1.00 beat NeuroBo Pharmaceuticals' score of 0.00 indicating that Sentage is being referred to more favorably in the news media. Company Overall Sentiment NeuroBo Pharmaceuticals Neutral Sentage Positive Which has more risk & volatility, NRBO or SNTG? NeuroBo Pharmaceuticals has a beta of -0.26, indicating that its stock price is 126% less volatile than the S&P 500. Comparatively, Sentage has a beta of 2.44, indicating that its stock price is 144% more volatile than the S&P 500. Which has stronger valuation & earnings, NRBO or SNTG? Sentage has higher revenue and earnings than NeuroBo Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/ASentage$146.47K31.60-$1.90MN/AN/A Do analysts rate NRBO or SNTG? NeuroBo Pharmaceuticals presently has a consensus price target of $10.00, indicating a potential upside of 1,253.18%. Given NeuroBo Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts plainly believe NeuroBo Pharmaceuticals is more favorable than Sentage.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroBo Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Sentage 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in NRBO or SNTG? NeuroBo Pharmaceuticals received 27 more outperform votes than Sentage when rated by MarketBeat users. CompanyUnderperformOutperformNeuroBo PharmaceuticalsOutperform Votes2775.00% Underperform Votes925.00% SentageN/AN/A Do institutionals & insiders believe in NRBO or SNTG? 1.4% of NeuroBo Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.1% of Sentage shares are owned by institutional investors. 1.1% of NeuroBo Pharmaceuticals shares are owned by insiders. Comparatively, 62.4% of Sentage shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummarySentage beats NeuroBo Pharmaceuticals on 8 of the 13 factors compared between the two stocks. Get Sentage News Delivered to You Automatically Sign up to receive the latest news and ratings for SNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNTG vs. The Competition Export to ExcelMetricSentageNondepository credit institutions IndustryFinance SectorNASDAQ ExchangeMarket Cap$4.67M$6.82B$10.87B$7.35BDividend YieldN/A4.72%5.77%4.31%P/E RatioN/A15.7621.5617.82Price / Sales31.609.0625.5197.72Price / CashN/A42.1517.6234.64Price / Book0.381.982.503.98Net Income-$1.90M$524.31M$1.04B$247.81M7 Day Performance1.91%1.99%1.82%3.19%1 Month Performance-11.76%-14.66%-4.03%-7.70%1 Year Performance-15.82%0.99%535.48%1.49% Sentage Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNTGSentage1.5392 of 5 stars$1.65+1.5%N/A-15.8%$4.67M$146,472.000.0020Upcoming EarningsShort Interest ↓Positive NewsNRBONeuroBo PharmaceuticalsN/A$1.84+26.9%$10.00+443.5%-78.1%$15.85MN/A0.0010Gap UpHigh Trading VolumeGLBZGlen Burnie Bancorp1.0353 of 5 stars$4.78-5.5%N/A+1.8%$13.87M$12.07M-119.5080Upcoming EarningsShort Interest ↑JFU9F0.6034 of 5 stars$1.09-1.3%N/A-61.2%$12.79M$295.14M0.00740Positive NewsGap UpANYSphere 3D2.4395 of 5 stars$0.48-6.8%$3.00+525.1%-57.3%$12.56M$16.61M-0.6020Analyst ForecastShort Interest ↓News CoverageBTCTBTC Digital1.2708 of 5 stars$3.50-1.1%N/A+26.8%$11.54M$8.48M0.0016Upcoming EarningsShort Interest ↓Positive NewsGRYPGryphon Digital Mining0.6657 of 5 stars$0.16-1.6%N/A-88.6%$10.97M$20.54M-0.29200AIHSSenmiao Technology0.0492 of 5 stars$0.90flatN/A+4.4%$9.47M$5.88M-2.81150Positive NewsMCVTMill City Ventures III1.7913 of 5 stars$1.48+1.4%N/A-43.3%$9.45M$3.57M-21.142Short Interest ↓Positive NewsGREEGreenidge Generation2.9858 of 5 stars$0.65-4.5%$4.00+517.8%-73.6%$9.37M$59.53M0.00680News CoveragePositive NewsSLNHSoluna1.2806 of 5 stars$0.63+2.1%N/A-71.9%$7.89M$38.02M-0.0460News CoverageGap Up Related Companies and Tools Related Companies NeuroBo Pharmaceuticals Alternatives Glen Burnie Bancorp Alternatives 9F Alternatives Sphere 3D Alternatives BTC Digital Alternatives Gryphon Digital Mining Alternatives Senmiao Technology Alternatives Mill City Ventures III Alternatives Greenidge Generation Alternatives Soluna Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNTG) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sentage Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sentage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNTG Stock Free SNTG Stock Alerts